-
Product Name
Anti-VSIG4 antibody
- Documents
-
Description
Rabbit Polyclonal to Human VSIG4
-
Tested applications
ELISA, IHC-P
-
Species reactivity
Human VSIG4
-
Alternative names
CRIg antibody; Z39IG antibody; CRIg antibody; Z39IG antibody; BC025105 antibody; A530061A11 antibody; A530061A11 antibody; BC025105 antibody; CRIg antibody; CRIg antibody; MGC36211 antibody; RP23-23B17.3 antibody; RP6-159A1.1 antibody; Vsig4 antibody; VSIG4 antibody; Z39IG antibody; Z39IG antibody
- Immunogen
-
Isotype
Rabbit IgG
-
Preparation
Produced in rabbits immunized with purified, recombinant Human VSIG4 . VSIG4 specific IgG was purified by Human VSIG4 affinity chromatography.
-
Clonality
Polyclonal
-
Formulation
0.2 μm filtered solution in PBS
-
Storage instructions
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles. -
Applications
ELISA: 0.1-0.2 μg/ml
This antibody can be used at 0.1-0.2 μg/ml with the appropriate secondary reagents to detect Human VSIG4.
IHC-P: 0.1-2 μg/mL
-
Validations
Human VSIG4 Immunohistochemistry(IHC) 14710
Human VSIG4 Immunohistochemistry(IHC) 14711
-
Background
VSIG4 (V-set and immunoglobulin domain containing 4), also known as complement receptor of the immunoglobulin superfamily (CRIg) and Z39Ig, is a type I transmembrane glycoprotein. It is a B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type I g domain and a truncated C-type I g domain. VSIG4 is exclusively expressed on tissue resident macrophages and binds to multimers of C3b and iC3b that are covalently attached to particle surfaces. No VSIG4 expression appears to be present in T and B cells. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. Mouse VSIG4 is synthesized as a 280 amino acid precursor that contains a signal sequence, an V-type I g domain (aa 36-115), one potential N-linked glycosylation site, and a single transmembrane domain. The V-type I g domain of mouse VSIG4 shares 86% and 80% aa sequence identity with the V-type I g domains of rat and human VSIG4, respectively.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"